FABISPRAY IS THE FIRST NASAL SPRAY FOR COVID-19 PATIENTS IN INDIA.
Glenmark, a Mumbai-based global pharma firm known for its innovation, has launched Nitric Oxide Nasal Spray (FabiSpray) in India in collaboration with SaNOtize for the treatment of adult COVID-19 patients.
